Sygen
Sygen Uses, Dosage, Side Effects, Food Interaction and all others data.
Sygen (Sygen, AGF 2) has been investigated for the treatment of Parkinson Disease. It is a naturally occurring substance in the nerve cell’s membrane that is thought to play a role in cell growth, development, and repair. Sygen completed phase 2 trials for parkinson's disease (PD) treatment. Sygen appears to be beneficial in patients with severe spinal cord injury. Treatment results in a 52% decrease in mortality 48 hours after the induction of ischemia in gerbils by permanent unilateral ligation of the common carotid artery.
Trade Name | Sygen |
Generic | Siagoside |
Siagoside Other Names | Ganglioside GM1 lactone, Siagoside, Siagosido, Siagosidum |
Type | |
Formula | C73H129N3O30 |
Weight | Average: 1528.826 Monoisotopic: 1527.866089766 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Sygen